BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31839828)

  • 1. PNCK depletion inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cells
    Xu Y; Wang J; Cai S; Chen G; Xiao N; Fu Y; Chen Q; Qiu S
    J Cancer; 2019; 10(27):6925-6932. PubMed ID: 31839828
    [No Abstract]   [Full Text] [Related]  

  • 2. Upregulation of PNCK Promotes Metastasis and Angiogenesis via Activating NF-
    Chen X; Weng Y; Li Y; Fu W; Huang Z; Pan Y; Hong W; Lin W; Lin X; Qiu S
    J Oncol; 2022; 2022():8541582. PubMed ID: 35535310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pnck overexpression in HER-2 gene-amplified breast cancer causes Trastuzumab resistance through a paradoxical PTEN-mediated process.
    Deb TB; Zuo AH; Barndt RJ; Sengupta S; Jankovic R; Johnson MD
    Breast Cancer Res Treat; 2015 Apr; 150(2):347-61. PubMed ID: 25773930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of serpin peptidase inhibitor clade C member 1 inhibits the growth of nasopharyngeal carcinoma cells.
    Xu J; Ying Y; Xiong G; Lai L; Wang Q; Yang Y
    Mol Med Rep; 2019 May; 19(5):3658-3666. PubMed ID: 30896875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of TFRC suppressed the progression of nasopharyngeal carcinoma by downregulating the PI3K/Akt/mTOR pathway.
    Feng G; Arima Y; Midorikawa K; Kobayashi H; Oikawa S; Zhao W; Zhang Z; Takeuchi K; Murata M
    Cancer Cell Int; 2023 Aug; 23(1):185. PubMed ID: 37644594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
    FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing c-Jun inhibits autophagy and abrogates radioresistance in nasopharyngeal carcinoma by activating the PI3K/AKT/mTOR pathway.
    Sun Y; Chen K; Lin G; Wan F; Chen L; Zhu X
    Ann Transl Med; 2021 Jul; 9(13):1085. PubMed ID: 34422997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway.
    Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F
    Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of RNA interference targeting four different genes on the growth and proliferation of nasopharyngeal carcinoma CNE-2Z cells.
    Song Y; Dong MM; Yang HF
    Cancer Gene Ther; 2011 Apr; 18(4):297-304. PubMed ID: 21233856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of 7RH, a discoidin domain receptor 1 inhibitor, alone or in combination with dasatinib exhibits antitumor effects in nasopharyngeal carcinoma cells.
    Lu QP; Chen WD; Peng JR; Xu YD; Cai Q; Feng GK; Ding K; Zhu XF; Guan Z
    Oncol Lett; 2016 Nov; 12(5):3598-3608. PubMed ID: 27900042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of POLG on Radiosensitivity of Nasopharyngeal Carcinoma Cells.
    Chen R; Wang Z; Lan R; Huang F; Chen J; Xu Y; Zhang H; Zhang L
    Cancer Biother Radiopharm; 2018 May; 33(4):146-154. PubMed ID: 29763377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of β-Catenin Decreases the Radiosensitivity of Human Nasopharyngeal Carcinoma CNE-2 Cells.
    He H; Lin K; Su Y; Lin S; Zou C; Pan J; Zhou Y; Chen C
    Cell Physiol Biochem; 2018; 50(5):1929-1944. PubMed ID: 30396174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts.
    Lin YT; Wang HC; Chuang HC; Hsu YC; Yang MY; Chien CY
    J Mol Med (Berl); 2018 Dec; 96(12):1407-1418. PubMed ID: 30374682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
    Shi J; Tan S; Song L; Song L; Wang Y
    Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatorial gene targeting hTERT and BI-1 in CNE-2 nasopharyngeal carcinoma cell line.
    Liang Y; Li X; Lin R; Zhang X; Wang H; Tan N; Li K; Tang X; Zhou K; Li T
    Biomed Rep; 2013 Mar; 1(2):285-293. PubMed ID: 24648937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium butyrate induces autophagic apoptosis of nasopharyngeal carcinoma cells by inhibiting AKT/mTOR signaling.
    Huang W; Zeng C; Liu J; Yuan L; Liu W; Wang L; Zhu H; Xu Y; Luo Y; Xie D; Jiang X; Ren C
    Biochem Biophys Res Commun; 2019 Jun; 514(1):64-70. PubMed ID: 31023529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-21 depletion by CRISPR/Cas9 in CNE2 nasopharyngeal cells hinders proliferation and induces apoptosis by targeting the PI3K/AKT/MOTOR signaling pathway.
    Xiao Z; Chen Y; Cui Z
    Int J Clin Exp Pathol; 2020; 13(4):738-745. PubMed ID: 32355522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FBXL10 contributes to the progression of nasopharyngeal carcinoma via involving in PI3K/mTOR pathway.
    Ren Y; Wu L; Li X; Li W; Yang Y; Zhang M
    Neoplasma; 2015; 62(6):925-31. PubMed ID: 26458315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Coding RNA Pvt1 Promotes Cancer Stem Cell-Like Traits in Nasopharyngeal Cancer via Inhibiting miR-1207.
    Cui M; Chang Y; Fang QG; Du W; Wu JF; Wang JH; Liu ST; Luo SX
    Pathol Oncol Res; 2019 Oct; 25(4):1411-1422. PubMed ID: 30141114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.